China SXT Pharmaceuticals, Inc. SEC filings SXTC
China SXT Pharmaceuticals, Inc. has 169 filings in SEC EDGAR's recent list, going back to Dec 4, 2017. Its latest annual report, Form 20-F, was filed on Jul 1, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 21, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Jul 1, 2026 | Mar 31, 2026 |
| 20-F | Annual report (foreign issuer) | Jul 31, 2025 | Mar 31, 2025 |
| 20-F | Annual report (foreign issuer) | Aug 13, 2024 | Mar 31, 2024 |
| 20-F | Annual report (foreign issuer) | Jul 31, 2023 | Mar 31, 2023 |
| 20-F/A | Amended annual report (foreign issuer) | May 19, 2023 | Mar 31, 2022 |
| 20-F | Annual report (foreign issuer) | Jul 18, 2022 | Mar 31, 2022 |
| 20-F | Annual report (foreign issuer) | Aug 13, 2021 | Mar 31, 2021 |
| 20-F | Annual report (foreign issuer) | Jul 31, 2020 | Mar 31, 2020 |
| 20-F/A | Amended annual report (foreign issuer) | Aug 19, 2019 | Mar 31, 2019 |
| 20-F | Annual report (foreign issuer) | Aug 15, 2019 | Mar 31, 2019 |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SXTC (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Virgin Islands, British
- Headquarters
- Taizhou
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1723980
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.